A detailed history of Great West Life Assurance CO transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 5,486 shares of PLRX stock, worth $63,253. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,486
Previous 5,486 -0.0%
Holding current value
$63,253
Previous $82,000 28.05%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$14.58 - $20.15 $52,706 - $72,842
3,615 Added 193.21%
5,486 $95,000
Q4 2022

Feb 10, 2023

BUY
$17.0 - $25.43 $31,807 - $47,579
1,871 New
1,871 $36,000
Q2 2022

Aug 09, 2022

SELL
$4.11 - $8.75 $2,733 - $5,818
-665 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$19.89 - $32.99 $13,226 - $21,938
665 New
665 $15,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $561M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.